Hepatitis C Therapy – Related Haematological Side Effects are Associated with Treatment Outcome / Hematološka Neželjena Dejstva Terapije Hepatitisa C Su Povezana Sa Ishodom Lecenja

Online veröffentlicht: 14. Apr. 2016

Seitenbereich: 9 - 14

Eingereicht: 21. Apr. 2015

Akzeptiert: 06. Juli 2015

DOI: https://doi.org/10.1515/sjecr-2015-0036

Schlüsselwörter

chronic hepatitis C, pegylated interferon alpha 2a, ribavirin, anaemia, thrombocytopenia, leucopoenia, neutropenia

© 2016

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.